Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × calcipotriene × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiodermatitis 1 Neoplasms 1

Interventions

Cisplatin 245 Carboplatin 176 Oxaliplatin 168 Capecitabine 166 Docetaxel 159 apatinib 155 Paclitaxel 147 Gemcitabine 139 Bevacizumab 139 Radiotherapy 134 camrelizumab 130 Fluorouracil 129 Cyclophosphamide 118 Irinotecan 112 Drug Therapy 94 Etoposide 92 sintilimab 91 S 1 (combination) 79 Leucovorin 74 anlotinib 73 Doxorubicin 72 pembrolizumab 70 tislelizumab 68 toripalimab 67 Pemetrexed 67 Dexamethasone 63 Rituximab 62 Neoadjuvant Therapy 60 Cetuximab 59 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00445250 2007-03-08

The Role of Calcipotriol as Radioprotector of Skin

Rabin Medical Center

Phase 2 Unknown

Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡